Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
2,019%
upside
4 price targets
|
0
%
|
|
|
|
641%
upside
3 price targets
|
0
%
|
|
|
|
445%
upside
5 price targets
|
0
%
|
|
|
4
Iovance Biotherapeutics
IOVA
$857M
|
440%
upside
3 price targets
|
0
%
|
|
|
344%
upside
5 price targets
|
0
%
|
|
|
|
308%
upside
4 price targets
|
0
%
|
|
|
|
299%
upside
6 price targets
|
0
%
|
|
|
|
279%
upside
4 price targets
|
0
%
|
|
|
|
269%
upside
3 price targets
|
0
%
|
|
|
|
266%
upside
3 price targets
|
0
%
|
|
|
11
Candel Therapeutics
CADL
$317M
|
238%
upside
4 price targets
|
0
%
|
|
|
233%
upside
4 price targets
|
0
%
|
|
|
|
232%
upside
3 price targets
|
0
%
|
|
|
|
230%
upside
3 price targets
|
0
%
|
|
|
|
229%
upside
4 price targets
|
0
%
|
|
|
|
226%
upside
3 price targets
|
0
%
|
|
|
|
207%
upside
6 price targets
|
0
%
|
|
|
|
202%
upside
3 price targets
|
0
%
|
|
|
|
195%
upside
4 price targets
|
0
%
|
|
|
|
192%
upside
5 price targets
|
0
%
|
|
|
|
185%
upside
3 price targets
|
0
%
|
|
|
|
184%
upside
4 price targets
|
0
%
|
|
|
|
181%
upside
10 price targets
|
0
%
|
|
|
|
177%
upside
3 price targets
|
0
%
|
|
|
|
177%
upside
5 price targets
|
0
%
|
|